Best Stocks : SandRidge Energy, Inc. (NYSE:SD), Hertz Global Holdings, Inc. (NYSE:HTZ), Financial Engines, Inc. (NASDAQ:FNGN), Delcath Systems, Inc. (NASDAQ:DCTH), PAG

SandRidge Energy (NYSE:SD) SVP Wayne Chang acquired 10,088 shares of SandRidge Energy stock in a transaction dated Friday, September 12th. The stock was purchased at an average price of $4.96 per share, for a total transaction of $50,036.48. Following the transaction, the senior vice president now directly owns 328,061 shares of the company’s stock, valued at approximately $1,627,183. SandRidge Energy, Inc. (NYSE:SD) belongs to Basic … Continue reading Best Stocks : SandRidge Energy, Inc. (NYSE:SD), Hertz Global Holdings, Inc. (NYSE:HTZ), Financial Engines, Inc. (NASDAQ:FNGN), Delcath Systems, Inc. (NASDAQ:DCTH), PAG

STO Second Quarter Production Has Modest Rise

Santos’s second-quarter production rose 2% to 12.4 million barrels of oil equivalent (mmboe), marginally below expectations, and full-year 2013 production guidance has been reduced by 3% to between 52 and 55 mmboe. The decline reflects deferred oil and gas production from Chim Sao in Vietnam due to power system constraints, steeper than- expected natural field decline at Sangu, and deferred Carnarvon production due to poor … Continue reading STO Second Quarter Production Has Modest Rise

Hot Alert : Groupon, Inc. (NASDAQ:GRPN), Himax Technologies, Inc. (NASDAQ:HIMX), Pool Corp. (NASDAQ:POOL), Arrowhead Research Corp. (NASDAQ:ARWR), Shinhan Financial Group Company Limited (NYSE:SHG)

Groupon, Inc. (NASDAQ:GRPN) announced that it intends to hold a conference call to discuss its third quarter 2014 financial results on Thursday, October 30, 2014, at 5:00pm EDT. Groupon, Inc. (NASDAQ:GRPN) belongs to Technology sector. Its net profit margin is -5.00% and weekly performance is -0.30%. On last trading day company shares ended up $6.68. Groupon, Inc. (NASDAQ:GRPN) distance from 50-day simple moving average (SMA50) … Continue reading Hot Alert : Groupon, Inc. (NASDAQ:GRPN), Himax Technologies, Inc. (NASDAQ:HIMX), Pool Corp. (NASDAQ:POOL), Arrowhead Research Corp. (NASDAQ:ARWR), Shinhan Financial Group Company Limited (NYSE:SHG)

Top News : EMC Corporation (NYSE:EMC), Schlumberger Limited (NYSE:SLB), Cavium, Inc. (NASDAQ:CAVM), The ExOne Company (NASDAQ:XONE), athenahealth, Inc. (NASDAQ:ATHN),

The EMC Corporation (NYSE:EMC), the computer storage company now facing pressure from a big activist hedge fund, had held discussions with Hewlett-Packard about a merger, though those talks have since ended, a person briefed on the matter said on Sunday. EMC Corporation (NYSE:EMC) belongs to Technology sector. Its net profit margin is 11.00% and weekly performance is -0.40%. On last trading day company shares ended … Continue reading Top News : EMC Corporation (NYSE:EMC), Schlumberger Limited (NYSE:SLB), Cavium, Inc. (NASDAQ:CAVM), The ExOne Company (NASDAQ:XONE), athenahealth, Inc. (NASDAQ:ATHN),

Eye Catching Stocks : Bitauto Holdings (NYSE:BITA), Intel (NASDAQ:INTC), Alphatec Holdings, Inc. (NASDAQ:ATEC), International Bancshares Corporation (NASDAQ:IBOC), The First Marblehead (NYSE:FMD),

Bitauto Holdings Limited (NYSE:BITA) provides Internet content and marketing services for the automotive industry primarily in the People’s Republic of China. BITA has a PE ratio of 158.3. Currently there are 2 analysts that rate Bitauto Holdings a buy, no analysts rate it a sell, and none rate it a hold. Bitauto Holdings Limited (NYSE:BITA) belongs to Technology sector. Its net profit margin is 18.30% … Continue reading Eye Catching Stocks : Bitauto Holdings (NYSE:BITA), Intel (NASDAQ:INTC), Alphatec Holdings, Inc. (NASDAQ:ATEC), International Bancshares Corporation (NASDAQ:IBOC), The First Marblehead (NYSE:FMD),

Top News : Repros Therapeutics (NASDAQ:RPRX), J. C. Penney Company (NYSE:JCP), Sutron (NASDAQ:STRN), Microsoft Corporation (NASDAQ:MSFT), Journal Communications Inc. (NYSE:JRN)

Repros Therapeutics Inc. (NASDAQ:RPRX) is up almost 20% during trading, on news of successful trial results for its low testosterone treating drug. The trial of the drug was being conducted against a leading treatment of low testosterone and a placebo with two primary end-points. Repros’s drug Androxal showed better results in both measures of the trial and also had statistically significant results for the secondary … Continue reading Top News : Repros Therapeutics (NASDAQ:RPRX), J. C. Penney Company (NYSE:JCP), Sutron (NASDAQ:STRN), Microsoft Corporation (NASDAQ:MSFT), Journal Communications Inc. (NYSE:JRN)